Konstantinos Drougkas

Comprehensive clinical evaluation of CAR-T cell immunotherapy for solid tumors: a path moving forward or a dead end?

E. Kotteas, I. Trontzas, I. Koumprentziotis, 2022, Journal of Cancer Research and Clinical Oncology.

Bcl-2 pathway inhibition in solid tumors: a review of clinical trials

E. Kotteas, I. Trontzas, I. Koumprentziotis, 2023, Clinical and Translational Oncology.

Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives

G. Gomatou, E. Kotteas, Konstantinos Drougkas, 2023, Current oncology.

CAR-T Cell Therapy in Pancreatic and Biliary Tract Cancers: An Updated Review of Clinical Trials.

G. Gomatou, Konstantinos Drougkas, Konstantinos Karampinos, 2024, Journal of gastrointestinal cancer.

Cyclin-Dependent Kinase 4/6 Inhibitors as Neoadjuvant Therapy of Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: What do we Know so Far?

E. Kotteas, Konstantinos Drougkas, Konstantinos Karampinos, 2024, Clinical breast cancer.

Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options

C. Mavragani, Charalampos Skarlis, Konstantinos Drougkas, 2024, Mediterranean journal of rheumatology.